Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines

Por Ahern, Charlotte Hsieh, Shen, Yu
Publicado em 2009

Risk-specific optimal cancer screening schedules: an application to breast cancer early detection

Por Ahern, Charlotte Hsieh, Cheng, Yi, Shen, Yu
Publicado em 2011

Pancreatic resection without routine intraperitoneal drainage

Por Fisher, William E, Hodges, Sally E, Silberfein, Eric J, Artinyan, Avo, Ahern, Charlotte H, Jo, Eunji, Brunicardi, F Charles
Publicado em 2011

Phase I Trial of Seneca Valley Virus (NTX-010) in Children with Relapsed / Refractory Solid Tumors: A Report of the Children’s Oncology Group

Por Burke, Michael J., Ahern, Charlotte, Weigel, Brenda J., Poirier, John T., Rudin, Charles M., Chen, Yingbei, Cripe, Timothy, Bernhardt, M. Brooke, Blaney, Susan M.
Publicado no Pediatr Blood Cancer (2014)

Downregulation of ZIP4 by RNA Interference Inhibits Pancreatic Cancer Growth and Increases the Survival of Nude Mice with Pancreatic Cancer Xenografts

Por Li, Min, Zhang, Yuqing, Bharadwaj, Uddalak, Zhai, Qihui (Jim), Ahern, Charlotte H., Fisher, William E., Brunicardi, F. Charles, Logsdon, Craig D., Chen, Changyi, Yao, Qizhi
Publicado em 2009

Pediatric Phase I Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small-Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase I Con...

Por Mossé, Yael P., Lipsitz, Emily, Fox, Elizabeth, Teachey, David T., Maris, John M., Weigel, Brenda, Adamson, Peter C., Ingle, Mark A., Ahern, Charlotte H., Blaney, Susan M.
Publicado em 2012

A Phase I Trial and Viral Clearance Study of Reovirus (Reolysin) in Children with Relapsed or Refractory Extra-cranial Solid Tumors: A Children's Oncology Group Phase I Consortium...

Por Kolb, E. Anders, Sampson, Valerie, Stabley, Deborah, Walter, Alexa, Sol-Church, Katia, Cripe, Timothy, Hingorani, Pooja, Ahern, Charlotte Hsieh, Weigel, Brenda J., Zwiebel, James, Blaney, Susan M.
Publicado no Pediatr Blood Cancer (2015)

A Phase 1 Dosing Study of Ruxolitinib in Children with Relapsed or Refractory Solid tumors, Leukemias, or Myeloproliferative Neoplasms: A Children's Oncology Group Phase 1 Consorti...

Por Loh, Mignon L., Tasian, Sarah K., Rabin, Karen R., Brown, Patrick, Magoon, Daniel, Reid, Joel M., Chen, Xuejun, Ahern, Charlotte H., Weigel, Brenda J., Blaney, Susan M.
Publicado no Pediatr Blood Cancer (2015)

Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children’s Oncology Group study

Por DuBois, Steven G., Shusterman, Suzanne, Reid, Joel M., Ingle, Ashish M., Ahern, Charlotte H., Baruchel, Sylvain, Glade-Bender, Julia, Ivy, Percy, Adamson, Peter C., Blaney, Susan M.
Publicado em 2011

A Phase 1 Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children’s Oncology Group Phase 1 Consortium Study (ADVL1112)

Por Thompson, Patrick A., Drissi, Rachid, Muscal, Jodi A., Panditharatna, Eshini, Fouladi, Maryam, Ingle, Ashish M., Ahern, Charlotte H., Reid, Joel M., Lin, Tong, Weigel, Brenda J., Blaney, Susan M.
Publicado em 2013

A Phase I Trial and Pharmacokinetic Study of Aflibercept (VEGF Trap) in Children with Refractory Solid Tumors: A Children’s Oncology Group Phase I Consortium Report

Por Bender, Julia Glade, Blaney, Susan M., Borinstein, Scott, Reid, Joel M., Baruchel, Sylvain, Ahern, Charlotte, Ingle, Ashish M., Yamashiro, Darrell J., Chen, Alice, Weigel, Brenda, Adamson, Peter C., Park, Julie R.
Publicado em 2012

Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortiu...

Por Glade Bender, Julia L., Lee, Alice, Reid, Joel M., Baruchel, Sylvain, Roberts, Timothy, Voss, Stephan D., Wu, Bing, Ahern, Charlotte H., Ingle, Ashish M., Harris, Pamela, Weigel, Brenda J., Blaney, Susan M.
Publicado em 2013

LONG-TERM OUTCOME OF CENTRALLY LOCATED LOW-GRADE GLIOMA IN CHILDREN

Por Terashima, Keita, Chow, Kevin, Jones, Jeremy, Ahern, Charlotte, Jo, Eunji, Ellezam, Benjamin, Paulino, Arnold C., Okcu, M. Fatih, Su, Jack, Adesina, Adekunle, Mahajan, Anita, Dauser, Robert, Whitehead, William, Lau, Ching, Chintagumpala, Murali
Publicado em 2014

A Pediatric Phase 1 Trial Of Vorinostat And Temozolomide In Relapsed Or Refractory Primary Brain Or Spinal Cord Tumors: A Children’s Oncology Group Phase 1 Consortium Study

Por Hummel, Trent R., Wagner, Lars, Ahern, Charlotte, Fouladi, Maryam, Reid, Joel M., McGovern, Renee M., Ames, Matthew M., Gilbertson, Richard J., Horton, Terzah, Ingle, Ashish M., Weigel, Brenda, Blaney, Susan M.
Publicado em 2013

Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma

Por Allen-Rhoades, Wendy, Kurenbekova, Lyazat, Satterfield, Laura, Parikh, Neha, Fuja, Daniel, Shuck, Ryan L, Rainusso, Nino, Trucco, Matteo, Barkauskas, Donald A, Jo, Eunji, Ahern, Charlotte, Hilsenbeck, Susan, Donehower, Lawrence A, Yustein, Jason T
Publicado no Cancer Med (2015)

Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children’s Oncology Group Study

Por DuBois, Steven G., Shusterman, Suzanne, Ingle, Ashish M., Ahern, Charlotte H., Reid, Joel M., Wu, Bing, Baruchel, Sylvain, Glade-Bender, Julia, Ivy, Percy, Grier, Holcombe E., Adamson, Peter C., Blaney, Susan M.
Publicado em 2011

A Phase I Trial of Vorinostat and Bortezomib in Children with Refractory or Recurrent Solid Tumors: A Children’s Oncology Group Phase I Consortium Study (ADVL0916)

Por Muscal, Jodi A., Thompson, Patrick A., Horton, Terzah M., Ingle, Ashish M., Ahern, Charlotte H., McGovern, Renee M., Reid, Joel M., Ames, Matthew M., Espinoza-Delgado, Igor, Weigel, Brenda J., Blaney, Susan M.
Publicado em 2012

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children’s Oncology Group phase 1 consortium study

Por Mossé, Yael P, Lim, Megan S, Voss, Stephan D, Wilner, Keith, Ruffner, Katherine, Laliberte, Julie, Rolland, Delphine, Balis, Frank M, Maris, John M, Weigel, Brenda J, Ingle, Ashish M, Ahern, Charlotte, Adamson, Peter C, Blaney, Susan M
Publicado em 2013

A Phase I Trial Of MK-2206 In Children with Refractory Malignancies: A Children's Oncology Group Study

Por Fouladi, Maryam, Perentesis, John P., Phillips, Christine L., Leary, Sarah, Reid, Joel M., McGovern, Renee M., Ingle, Ashish M., Ahern, Charlotte H., Ames, Matthew M., Houghton, Peter, Doyle, L. Austin, Weigel, Brenda, Blaney, Susan M.
Publicado no Pediatr Blood Cancer (2014)

A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children’s Oncology Group Phase 1 Consortium Report

Por Fouladi, Maryam, Perentesis, John P., Wagner, Lars M., Vinks, Alexander A., Reid, Joel M., Ahern, Charlotte, Thomas, George, Mercer, Carol A., Krueger, Darcy A., Houghton, Peter J., Doyle, L. Austin, Chen, Helen, Weigel, Brenda, Blaney, Susan M.
Publicado no Clin Cancer Res (2014)